CellSource Co

CellSource Co Graham Number

The Graham Number of CellSource Co (4880.T) as of Nov 5, 2026 is 60.59 JPY. In the previous year, Graham Number was 286.87 JPY — a change of -78.88% (lower).

Graham Number

60.59JPY

YoY

-78.88%

Last updated:

Graham Number of CellSource Co is 2025 60.59 JPY. Graham Number of CellSource Co was 2024 286.87 JPY. It decreases by -78.88% lower compared to the previous year.

The CellSource Co Graham Number history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Graham Number
Date
Graham Number
Jan 1, 2018
66.52 JPY
Jan 1, 2019
145.16 JPY
Jan 1, 2020
182.04 JPY
Jan 1, 2021
323.47 JPY
Jan 1, 2022
477.00 JPY
Jan 1, 2023
578.68 JPY
Jan 1, 2024
286.87 JPY
Jan 1, 2025
60.59 JPY
The CellSource Co Graham Number history
YEARGraham NumberYoY
60.59JPY-78.88%
286.87JPY-50.43%
578.68JPY+21.32%
477.00JPY+47.46%
323.47JPY+77.69%
182.04JPY+25.41%
145.16JPY+118.21%
66.52JPY+83.07%
36.34JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CellSource Co Stock analysis

What does CellSource Co do? CellSource Co., Ltd. generates revenue through its Regenerative Medicine Related business segment, which provides contracted services for processing tissues and cells from fat and blood to medical institutions, along with support services for regenerative medicine laws and regulations related to safety assurance. The company also sells medical equipment within this segment. The Consumer business segment focuses on selling cosmetics and facial products directly to general consumers. Both segments operate under the company's brand without additional brand names mentioned in the description. The Regenerative Medicine Related business segment targets medical institutions and regulatory compliance support for regenerative medicine safety, while the Consumer business segment serves general consumers seeking cosmetics and facial care products. The company's products include processed tissue and cell services, regulatory support, medical equipment, and consumer skincare items, all sold under the CellSource brand. CellSource Co., Ltd. employs 109 full-time employees to manage its two business segments, with the Regenerative Medicine Related segment handling medical services and equipment sales, and the Consumer segment focusing on direct-to-consumer product sales. The company's revenue streams are derived from these two distinct operational areas without any additional external partnerships or third-party brands. CellSource Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CellSource Co stock

Graham Number of CellSource Co is 60.59 JPY in 2025.

On Eulerpool you can find the complete historical development of Graham Number CellSource Co since 2006 – with annual values, charts, and detailed analysis.

The Graham Number estimates the maximum fair price for a stock based on EPS and book value per share, following Benjamin Graham's value investing principles.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — CellSource Co

All Key Metrics — CellSource Co